Studies have shown that the GARP-TGF-β complex, together with platelet-secreted lactate, inhibits T-cell responses against melanoma and colorectal cancer, thus exerting suppressive effects on anti-tumor immunity (239, 246). This evidence concerns the gene TGFB1 and neoplasm.